Heartland Advisors Inc. reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 14.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,312,207 shares of the medical instruments supplier’s stock after selling 214,126 shares during the quarter. DENTSPLY SIRONA accounts for about 0.9% of Heartland Advisors Inc.’s holdings, making the stock its 29th largest holding. Heartland Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $16,652,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Mitsubishi UFJ Trust & Banking Corp lifted its position in DENTSPLY SIRONA by 1,836.7% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock valued at $1,344,000 after purchasing an additional 100,468 shares during the last quarter. Bank of Montreal Can increased its holdings in DENTSPLY SIRONA by 8.2% during the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after purchasing an additional 26,610 shares during the period. Commonwealth Equity Services LLC lifted its holdings in DENTSPLY SIRONA by 38.4% in the 3rd quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after buying an additional 223,339 shares during the period. CWM LLC grew its position in shares of DENTSPLY SIRONA by 84.3% in the 3rd quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock worth $5,336,000 after buying an additional 192,373 shares during the last quarter. Finally, Allianz Asset Management GmbH increased its stake in shares of DENTSPLY SIRONA by 63.6% during the third quarter. Allianz Asset Management GmbH now owns 1,355,643 shares of the medical instruments supplier’s stock valued at $17,203,000 after buying an additional 526,973 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
XRAY has been the subject of several research analyst reports. Barrington Research reaffirmed an “outperform” rating and issued a $14.00 target price on shares of DENTSPLY SIRONA in a research report on Monday, January 5th. Mizuho increased their price target on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 20th. JPMorgan Chase & Co. cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Barclays started coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price for the company. Finally, Wells Fargo & Company reduced their price target on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $14.25.
DENTSPLY SIRONA Price Performance
Shares of NASDAQ:XRAY opened at $12.95 on Tuesday. The business has a fifty day moving average price of $12.15 and a 200-day moving average price of $12.51. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company has a market capitalization of $2.58 billion, a PE ratio of -2.93, a PEG ratio of 1.02 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $19.27.
DENTSPLY SIRONA Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.48%.
Insider Activity at DENTSPLY SIRONA
In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is currently owned by insiders.
About DENTSPLY SIRONA
Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.
The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
